Published in Eur J Biochem on December 01, 2000
Decompensated heart failure is associated with reduced corin levels and decreased cleavage of pro-atrial natriuretic peptide. Circ Heart Fail (2011) 2.00
Hypertension in mice lacking the proatrial natriuretic peptide convertase corin. Proc Natl Acad Sci U S A (2005) 1.84
Corin overexpression improves cardiac function, heart failure, and survival in mice with dilated cardiomyopathy. Hypertension (2012) 1.60
Plasma soluble corin in patients with heart failure. Circ Heart Fail (2010) 1.36
Corin: new insights into the natriuretic peptide system. Kidney Int (2008) 1.35
Matriptase-2 (TMPRSS6): a proteolytic regulator of iron homeostasis. Haematologica (2009) 1.27
Membrane-anchored serine proteases in vertebrate cell and developmental biology. Annu Rev Cell Dev Biol (2011) 1.26
Mouse matriptase-2: identification, characterization and comparative mRNA expression analysis with mouse hepsin in adult and embryonic tissues. Biochem J (2003) 1.18
Protease corin expression and activity in failing hearts. Am J Physiol Heart Circ Physiol (2010) 1.16
Membrane-anchored serine proteases in health and disease. Prog Mol Biol Transl Sci (2011) 1.13
Chronic actions of a novel oral B-type natriuretic peptide conjugate in normal dogs and acute actions in angiotensin II-mediated hypertension. Circulation (2008) 1.04
Effects of anticoagulants on human plasma soluble corin levels measured by ELISA. Clin Chim Acta (2010) 0.99
Corin in clinical laboratory diagnostics. Clin Chim Acta (2011) 0.97
Corin mutations K317E and S472G from preeclamptic patients alter zymogen activation and cell surface targeting. [Corrected]. J Biol Chem (2014) 0.85
Cleavage specificity analysis of six type II transmembrane serine proteases (TTSPs) using PICS with proteome-derived peptide libraries. PLoS One (2014) 0.85
BNP molecular forms and processing by the cardiac serine protease corin. Adv Clin Chem (2013) 0.84
Corin in natriuretic peptide processing and hypertension. Curr Hypertens Rep (2014) 0.84
Distinct roles of N-glycosylation at different sites of corin in cell membrane targeting and ectodomain shedding. J Biol Chem (2014) 0.79
Role of corin and atrial natriuretic peptide in preeclampsia. Placenta (2012) 0.78
Role of corin in the regulation of blood pressure. Curr Opin Nephrol Hypertens (2016) 0.75
Atrial natriuretic peptide: a magic bullet for cancer therapy targeting Wnt signaling and cellular pH regulators. Curr Med Chem (2014) 0.75
A novel cytoplasmic tail motif regulates mouse corin expression on the cell surface. Biochem Biophys Res Commun (2015) 0.75
Localization of corin and atrial natriuretic peptide expression in human renal segments. Clin Sci (Lond) (2016) 0.75
Unique features of internal initiation of hepatitis C virus RNA translation. EMBO J (1995) 4.44
The complete nucleotide sequence of the RNA coding for the primary translation product of foot and mouth disease virus. Nucleic Acids Res (1984) 3.00
Type II transmembrane serine proteases. Insights into an emerging class of cell surface proteolytic enzymes. J Biol Chem (2001) 2.56
Chemical basis of antigenic variation in foot-and-mouth disease virus. Nature (1984) 2.52
Internal initiation of translation of hepatitis C virus RNA: the ribosome entry site is at the authentic initiation codon. RNA (1996) 2.45
All foot and mouth disease virus serotypes initiate protein synthesis at two separate AUGs. Nucleic Acids Res (1987) 2.22
A new and improved method for 3'-end labelling DNA using [alpha-32P]ddATP. Gene (1984) 1.78
Molecular and biological characterization of simian immunodeficiency virus macaque strain 32H proviral clones containing nef size variants. J Gen Virol (1994) 1.77
A steady-state and pre-steady-state kinetic analysis of the NTPase activity associated with the hepatitis C virus NS3 helicase domain. J Biol Chem (1996) 1.71
Transcriptional control and the role of silencers in transcriptional regulation in eukaryotes. Biochem J (1998) 1.60
Enalapril retards glomerular basement membrane thickening and albuminuria in the diabetic rat. Diabetologia (1989) 1.57
Two novel mucin genes down-regulated in colorectal cancer identified by differential display. Cancer Res (1999) 1.52
Induction of T-helper cell response to hepatitis B core antigen in chronic hepatitis B: a major factor in activation of the host immune response to the hepatitis B virus. Hepatology (1995) 1.50
Gene expression of lung squamous cell carcinoma reflects mode of lymph node involvement. Eur Respir J (2007) 1.43
Intestinal inflammation reduces expression of DRA, a transporter responsible for congenital chloride diarrhea. Am J Physiol (1998) 1.41
Enhanced venous thrombus resolution in plasminogen activator inhibitor type-2 deficient mice. J Thromb Haemost (2014) 1.41
Tissue factor and plasminogen activator inhibitor expression in the differentiation of myeloid leukemic cells. Leukemia (1993) 1.40
Novel signaling interactions between proteinase-activated receptor 2 and Toll-like receptors in vitro and in vivo. Mucosal Immunol (2009) 1.39
Plasminogen activator inhibitor type 2 inhibits tumor necrosis factor alpha-induced apoptosis. Evidence for an alternate biological function. J Biol Chem (1995) 1.38
Two initiation sites for foot-and-mouth disease virus polyprotein in vivo. J Gen Virol (1985) 1.35
The sequence of foot-and-mouth disease virus RNA to the 5' side of the poly(C) tract. Gene (1985) 1.31
Host cell selection of antigenic variants of foot-and-mouth disease virus. J Gen Virol (1989) 1.26
Reiterated repeat region variability in the ciliary adhesin gene of Mycoplasma hyopneumoniae. Microbiology (1998) 1.25
Multiple proteases in foot-and-mouth disease virus replication. J Virol (1984) 1.18
Neutralizing antibodies to all seven serotypes of foot-and-mouth disease virus elicited by synthetic peptides. Immunology (1990) 1.13
Kinetic characterization of the interaction between cytochrome oxidase and cytochrome c. J Biol Chem (1982) 1.10
Expression of antisense CD44 variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment. Cancer Res (1998) 1.04
Heterogeneity of MUC1 expression by human breast carcinoma cell lines in vivo and in vitro. Breast Cancer Res Treat (1999) 1.03
Analysis of NS3-mediated processing of the hepatitis C virus non-structural region in vitro. J Gen Virol (1994) 1.02
Neutralization epitopes of human rhinovirus type 2. J Gen Virol (1990) 1.01
Epitope mapping of foot-and-mouth disease virus with neutralizing monoclonal antibodies. J Gen Virol (1989) 1.01
Alternatively spliced variants of the cell adhesion molecule CD44 and tumour progression in colorectal cancer. Br J Cancer (1996) 0.98
Hepatitis C virus glycoprotein E2 binding to CD81: the role of E1E2 cleavage and protein glycosylation in bioactivity. Virology (2000) 0.98
The C-D interhelical domain of the serpin plasminogen activator inhibitor-type 2 is required for protection from TNF-alpha induced apoptosis. Cell Death Differ (1998) 0.96
Allelic loss on chromosome 7q in ovarian adenocarcinomas: two critical regions and a rearrangement of the PLANH1 locus. Oncogene (1996) 0.95
Benign fibrous histiocytoma of bone. Am J Surg Pathol (1985) 0.94
Gelatinous transformation of the bone marrow. Pathology (1983) 0.94
Survival of patients with biopsy-proven usual interstitial pneumonia and nonspecific interstitial pneumonia. Eur Respir J (2002) 0.93
Testisin, a new human serine proteinase expressed by premeiotic testicular germ cells and lost in testicular germ cell tumors. Cancer Res (1999) 0.92
Immunological properties of hepatitis B core antigen fusion proteins. Proc Natl Acad Sci U S A (1990) 0.91
Regulation of the plasminogen activator inhibitor-2 (PAI-2) gene in murine macrophages. Demonstration of a novel pattern of responsiveness to bacterial endotoxin. J Leukoc Biol (1999) 0.91
Foreign epitopes in immunodominant regions of hepatitis B core particles are highly immunogenic and conformationally restricted. Vaccine (1991) 0.90
Iron-induced bronchial injury. Histopathology (2002) 0.90
Cloning of the cDNA and localization of the gene encoding human NRBP, a ubiquitously expressed, multidomain putative adapter protein. Genomics (2000) 0.88
Expression in yeast of amino-terminal peptide fusions to hepatitis B core antigen and their immunological properties. Biotechnology (N Y) (1990) 0.87
A synthetic peptide which elicits neutralizing antibody against human rhinovirus type 2. J Gen Virol (1987) 0.87
Serological prospects for peptide vaccines against foot-and-mouth disease virus. J Gen Virol (1989) 0.87
Localization, expression and genomic structure of the gene encoding the human serine protease testisin. Biochim Biophys Acta (2000) 0.86
The nature and spatial distribution of amino acid substitutions conferring resistance to neutralizing monoclonal antibodies in human rhinovirus type 2. J Gen Virol (1993) 0.86
Nephropathy in model combining genetic hypertension with experimental diabetes. Enalapril versus hydralazine and metoprolol therapy. Diabetes (1990) 0.85
Plasminogen activator inhibitor type-2 (PAI-2) gene transcription requires a novel NF-kappaB-like transcriptional regulatory motif. Eur J Biochem (1999) 0.85
The deleted in colon cancer (DCC) gene is consistently expressed in colorectal cancers and metastases. Oncogene (1996) 0.83
Resonance Raman spectroscopy of cytochrome oxidase using Soret excitation: selective enhancement, indicator bands, and structural significance for cytochromes a and a3. Biochemistry (1981) 0.83
Screening for activating EGFR mutations in surgically resected nonsmall cell lung cancer. Eur Respir J (2011) 0.83
Human trypsinogen in colorectal cancer. Int J Cancer (2001) 0.83
Hypermethylation of the 5' CpG island of the gene encoding the serine protease Testisin promotes its loss in testicular tumorigenesis. Br J Cancer (2005) 0.83
Organization and chromosomal localization of the murine Testisin gene encoding a serine protease temporally expressed during spermatogenesis. Eur J Biochem (2001) 0.82
Peptide vaccines based on enhanced immunogenicity of peptide epitopes presented with T-cell determinants or hepatitis B core protein. Methods Enzymol (1989) 0.82
In vitro cleavage of hepatitis C virus polyprotein substrates by purified recombinant NS3 protease. J Gen Virol (1995) 0.82
Sodium butyrate differentially modulates plasminogen activator inhibitor type-1, urokinase plasminogen activator, and its receptor in a human colon carcinoma cell. Teratog Carcinog Mutagen (1993) 0.82
Modification of the leader protein (Lb) of foot-and-mouth disease virus. J Gen Virol (1988) 0.81
Picornavirus receptor down-regulation by plasminogen activator inhibitor type 2. J Virol (1999) 0.81
Spectroscopic characterization of compound C and related derivatives of cytochrome oxidase. Proc Natl Acad Sci U S A (1981) 0.81
Accumulation of p16CDKN2A in response to ultraviolet irradiation correlates with late S-G(2)-phase cell cycle delay. Cancer Res (1996) 0.81
The nucleotide sequence of the structural-protein-coding region of foot-and-mouth disease virus serotype SAT3. Gene (1989) 0.80
Origin of glomerular crescents in rabbit nephrotoxic nephritis. J Pathol (1983) 0.79
Macrophages and glomerular crescent formation. Studies with rat nephrotoxic nephritis. Pathology (1983) 0.77
An orthotopic xenograft model of human nonseminomatous germ cell tumour. Br J Cancer (2001) 0.77
Characterisation of PAUSE-1, a powerful silencer in the human plasminogen activator inhibitor type 2 gene promoter. Nucleic Acids Res (2001) 0.76
Receptors for hepatitis C virus. J Virol (2000) 0.75
BcII RFLP of the plasminogen activator inhibitor type 2 gene (PLANH) on chromosome 18q21-q23. Nucleic Acids Res (1990) 0.75
DNase I hypersensitive sites in the 5' flanking region of the human plasminogen activator inhibitor type 2 (PAI-2) gene are associated with basal and tumor necrosis factor-alpha-induced transcription in monocytes. Eur J Biochem (1998) 0.75
In vitro translation of hepatitis A virus subgenomic RNA transcripts. J Gen Virol (1991) 0.75
Urokinase binding and catabolism by Hep G2 cells is plasminogen activator inhibitor-1 dependent, analogous to interactions of tissue-type plasminogen activator with these cells. Thromb Res (1995) 0.75
Life-threatening haemoptysis presenting as a late complication of an ovarian tumour. Int J Clin Pract (2001) 0.75
Expression and characterization of the HCV NS3 helicase domain. Methods Mol Med (1999) 0.75
Transesophageal echocardiographic abnormalities in a case of cardiac sarcoidosis. J Am Soc Echocardiogr (2001) 0.75
Expression and characterization of HCV NS3 protease. Methods Mol Med (1999) 0.75
Production of replication-deficient adenovirus recombinants. Methods Mol Med (1999) 0.75
Synthesis and secretion of a functional antibody in a vaccinia virus expression system. Mol Immunol (1992) 0.75
A 75 year old man with sideroblastic anemia. Aust N Z J Med (1986) 0.75
Hypermethylation of the 5' CpG island of the gene encoding the serine protease Testisin promotes its loss in testicular tumorigenesis. Br J Cancer (2015) 0.75
Synthetic peptides mimic subtype specificity of foot-and-mouth disease virus. FEBS Lett (1983) 0.75
Microvascular complications in cystic fibrosis-related diabetes mellitus: a case report. JOP (2000) 0.75